Alfresa Holdings Corporation (TYO:2784)

Japan · Delayed Price · Currency is JPY

2,140.50

-116.50 (-5.16%)

Aug 5, 2026, 3:30 PM JST

-2.06% (1Y)

Market Cap	375.47B -6.4%
Revenue (ttm)	3.10T +4.8%
Net Income	41.75B +52.4%
EPS	229.64 +55.6%
Shares Out	175.41M
PE Ratio	9.32
Forward PE	15.11
Dividend	71.00 (3.15%)
Ex-Dividend Date	Sep 29, 2026

Volume	1,542,800
Open	2,241.00
Previous Close	2,257.00
Day's Range	2,140.50 - 2,254.50
52-Week Range	2,055.00 - 2,685.50
Beta	-0.16
Analysts	Hold
Price Target	2,550.00 (+19.13%)
Earnings Date	Aug 5, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2003

Employees 12,525

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 2784

Full Company Profile

Financial Performance

In fiscal year 2026, Alfresa Holdings's revenue was 3.10 trillion, an increase of 4.83% compared to the previous year's 2.96 trillion. Earnings were 41.75 billion, an increase of 52.42%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 2784 stock is "Hold." The 12-month stock price target is ¥2,550, which is an increase of 19.13% from the latest price.

Price Target

¥2,550

(19.13% upside)

Analyst Consensus: Hold

Stock Forecasts